Solid Biosciences (SLDB) Enterprise Value: 2017-2024
Historic Enterprise Value for Solid Biosciences (SLDB) over the last 8 years, with Dec 2024 value amounting to $159.8 million.
- Solid Biosciences' Enterprise Value rose 63960.10% to $159.8 million in Q4 2024 from the same period last year, while for Dec 2024 it was $159.8 million, marking a year-over-year increase of 132.73%. This contributed to the annual value of $159.8 million for FY2024, which is 63960.10% up from last year.
- According to the latest figures from Q4 2024, Solid Biosciences' Enterprise Value is $159.8 million, which was up 63.26% from $97.9 million recorded in Q3 2024.
- Over the past 5 years, Solid Biosciences' Enterprise Value peaked at $303.5 million during Q4 2020, and registered a low of -$173.2 million during Q4 2022.
- In the last 3 years, Solid Biosciences' Enterprise Value had a median value of -$52.5 million in 2022 and averaged -$5.3 million.
- In the last 5 years, Solid Biosciences' Enterprise Value slumped by 1,073.20% in 2022 and then spiked by 63,960.10% in 2024.
- Solid Biosciences' Enterprise Value (Quarterly) stood at $303.5 million in 2020, then slumped by 104.86% to -$14.8 million in 2021, then crashed by 1,073.20% to -$173.2 million in 2022, then surged by 100.14% to $249,482 in 2023, then skyrocketed by 63,960.10% to $159.8 million in 2024.
- Its Enterprise Value was $159.8 million in Q4 2024, compared to $97.9 million in Q3 2024 and $27.3 million in Q2 2024.